What’s The Growth Forecast For Cellular Health Screening Market Through 2023-2032?
The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.
As per The Business Research Company’s Cellular Health Screening Global Market Report 2023, The global cellular health screening market is expected to grow from $2.69 billion in 2022 to $3.01 billion in 2023 at a compound annual growth rate (CAGR) of 12.1%. The global cellular health screening market size is expected to reach $4.55 billion in 2027 at a CAGR of 10.8%.
What was the major driver in the cellular health screening market?
The rise in chronic diseases is likely to drive the cellular health screening industry forward. Chronic diseases are medical conditions that persist for an extended period of time and demand ongoing management and care. By diagnosing persons with chronic diseases caused by factors such as genetic predisposition, lifestyle choices, environmental conditions, and underlying health difficulties, cellular health screening can help prevent disease or minimise the severity of sickness. According to the Centres for illness Control and Prevention, a US-based intergovernmental organisation, the most frequent type of heart illness in October 2022 was coronary heart disease, which afflicted around 20.1 million persons aged 20 and older. Someone has a heart attack every 40 seconds, and about 805,000 people in the United States have a heart attack each year. Furthermore, according to the National Library of Medicine, a federal government-run biomedical library in the United States, the number of people aged 50 and older in the United States with at least one chronic condition is expected to increase by 99.5% by 2023, from 71.522 million in 2020 to 142.66 million in 2050. As a result, the rise in chronic diseases is propelling the cellular health screening market forward.
View More On The Cellular Health Screening Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report
What was the key trend in the cellular health screening market?
Technological advances are a prominent trend that is gaining traction in the cellular health screening market. Companies in the cellular health screening industry are embracing new technologies in order to maintain their market position. For example, Axion BioSystems, a biotechnology firm based in the United States, will unveil the Maestro ZHT, a high-throughput live-cell screening platform, in November 2020. Whether comparing immune cell-mediated killing by CRISPR-derived CAR-T cells, vaccination efficiency, or chemotherapies against patient-derived tumour cells, the flexible Maestro ZHT will continuously monitor cells without labels or dyes. It includes robust turn-key software with regulatory compliance features to meet FDA 21 CFR Part 11 data traceability standards. Users can utilise it to measure kinetic cellular reactions and remotely monitor trials.
Which was the largest region in the cellular health screening market?
North America was the largest region in the cellular health screening market in 2022. Asia-Pacific is expected to be the fastest-growing region in the global cellular health screening market report during the forecast period. The regions covered in the global cellular health screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Who are the cellular health screening market prominent players?
Major players in the cellular health screening market are Bio-Reference Laboratories Inc., Laboratory Corporation, Quest Diagnostics, Cell Science Systems, Genova Diagnostics (GDX), Immundiagnostik AG, Life Length, Repeat Diagnostics Inc., Segterra Inc., SpectraCell Laboratories Inc., Telomere Diagnostics Inc., Zimetry LLC, Cleveland Heartlab Inc., Agilent Technologies Inc., DNA Labs India, and Bloom Diagnostics GmbH.
Key cellular health screening market segments
The global cellular health screening market is segmented –
1) By Test Type: Single Test Panels, Telomere Tests, Oxidative Stress Tests, Inflammation Tests, Heavy Metals Tests, Multi-test Panels
2) By Sample Type: Blood, Saliva, Serum, Urine
3) By Collection Site: Home, Office, Hospital, Diagnostic Labs
Request A Sample Of The Global Cellular Health Screening Market Report 2023:
The Cellular Health Screening Global Market Report 2023 provides a comprehensive overview on the cellular health screening market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies
Follow us on:
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model